How well listed pharmas did with net profits?
Both KOSPI and KOSDAQ listed pharmaceutical companies experienced a decrease in the average net profits in the first half of this year, and KOSDAQ pharmas had a larger decrease. On the other hand, KOSDAQ pharmas had a higher percentage of net profits to sales than KOSPI pharmas.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.